2023 AABB Annual Meeting On-Demand

AM23-ST-04-L - AM23-ST-04-L: THOR/AABB: Prehospital transfusion: the latest evidence and expert discussion (Live)

Oct 14, 2023 8:30am ‐ Oct 14, 2023 12:30pm

Credits: None available.

Overview
CE Information

Prehospital transfusion is becoming a common event in the USA and around the world. There are many factors to consider when implementing such a program, like which products should be transfused and when? Which emergency vehicles should carry these products? When should prehospital patients be transfused? How can these transfusions be monitored for adverse events both during and after the transfusion? What are the regulations concerning prehospital transfusion, and who will pay for it? This session will present the latest evidence and expert opinion from leaders in trauma resuscitation on these questions and more.

Learning Objectives:

Understand the medical and regulatory fundamentals of implementing a prehospital transfusion program
Evaluate the evidence for the use of blood products prehospital and selecting the RhD type of these products
Appreciate nature of trauma in pediatric patients and how it differs from adults

Moderator(s):

Luiz Amorim, MD, General Director, Hemorio
Denese Marks, PhD, Research Program Leader, Australian Red Cross Lifeblood

Speaker(s):

Andre Cap, MD
Melissa Cushing, MD, Executive Vice Chair, Weill Cornell Medicine Department of Pathology and Laboratory Medicine
Nancy Dunbar, MD, Medical Director, Blood Bank, Dartmouth-Hitchcock Medical Center
John Holcomb, MD, Professor of Surgery, University of Alabama at Birmingham
Robert Russell, MD, MPH, Associate Professor of Surgery, University of Alabama at Birmingham, Children's of Alabama
Molly Sherwood, Director of Research, Allo Hope Foundation
Phillip Spinella, MD, Professor of Surgery and Critical Care Medicine, University of Pittsburgh
Bethany Weathersby, MEd, Executive Director, The Allo Hope Foundation
CJ Winckler, MD, Associate Professor UT Health San Antonio / EMS Medical Director, UT Health San Antonio
Mark Yazer, MD, Professor of Pathology, Department of Pathology, University of Pittsburgh
Pampee Young, MD, PhD, Chief Medical Officer, American Red Cross

Disclosures

Luiz Amorim, MD:
No financial relationships to disclose
Andre Cap, MD:
Melissa Cushing, MD:
Cerus: Consultant/Advisory Board (Ongoing); CSL: Consultant/Advisory Board (Ongoing); Haemonetics: Consultant/Advisory Board (Ongoing); Octapharma: Consultant/Advisory Board (Ongoing)
Nancy Dunbar, MD:
No financial relationships to disclose
John Holcomb, MD:
Aspen Medical: Consultant/Advisory Board (Ongoing); BARDA: Consultant/Advisory Board (Ongoing); CCJ Medical: Full-time/Part-time Employee or Owner (Ongoing); decisio health: Full-time/Part-time Employee or Owner (Ongoing); Hemostatics: Consultant/Advisory Board (Ongoing); Oxyband: Consultant/Advisory Board (Ongoing); QinFlow: Consultant/Advisory Board (Ongoing); WFIRM: Consultant/Advisory Board (Ongoing); Zibrio: Consultant/Advisory Board (Ongoing)
Denese Marks, PhD:
Vitrafy Life Sciences: Consultant/Advisory Board (Ongoing)
Robert Russell, MD, MPH:
No financial relationships to disclose
Molly Sherwood:
Janssen Pharmaceuticals: Grant/Research Support (Ongoing)
Phillip Spinella, MD:
Cerus: Consultant/Advisory Board (Ongoing); Haima: Consultant/Advisory Board (Ongoing); Hemanext: Consultant/Advisory Board (Ongoing); Kalocyte: Stock Shareholder (self-managed) (Ongoing); Octapharma: Consultant/Advisory Board (Ongoing)
Bethany Weathersby, MEd:
No financial relationships to disclose
CJ Winckler, MD:
No financial relationships to disclose
Mark Yazer, MD:
grifols: Honoraria (Ongoing), Speaker's Bureau (Ongoing); Hemanext: Consultant/Advisory Board (Ongoing); Terumo: Honoraria (Ongoing), Speaker's Bureau (Ongoing)
Pampee Young, MD, PhD:
Cerus Co: Honoraria (Ongoing); Eluciderm: Consultant/Advisory Board (Ongoing), Full-time/Part-time Employee or Owner (Ongoing); Fresenius: Consultant/Advisory Board (Ongoing)

Credits

Credits: None available.